Threshold of 2 Millions marketed doses reached!


With sale of 2 000 854 doses in 2012, NUCLEUS follows its development. Semen sales increased by 3.8% in 2012. This growth in decreasing market is recognition of NUCLEUS by its customers. Qualities of NUCLEUS breeding stock are approved by our customers. "Thanks to work of everyone, NUCLEUS consolidates its leading place on French market" explains us Jacques GOURMELON, managing director. "This recognition encourages us to continue our breeding work on serious way"

© NUCLÉUS 2018 - Legal mention - Creation by Mediapilote - Privacy policy - Cookies policy